Home > Insider Trading > Filing (0000939767-17-000147)

Filing Details

Accession Number:: 0000939767-17-000147
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-09-14 19:14:54
Reporting Period:: 2017-09-12

Accepted Time:: 2017-09-14 19:14:54
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
939767	Exelixis Inc.	EXEL	Services-Commercial Physical & Biological Research (8731)	043257395

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1202096	Michael Morrissey	C/O Exelixis, Inc. 210 E. Grand Ave. South San Francisco CA 94080	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-09-12	100,000	$1.70	160,000	No	4	M	Direct
Common Stock	Disposition	2017-09-12	100,000	$26.59	60,000	No	4	S	Direct
Common Stock	Acquisiton	2017-09-13	100,000	$1.70	160,000	No	4	M	Direct
Common Stock	Disposition	2017-09-13	100,000	$27.04	60,000	No	4	S	Direct
Common Stock	Acquisiton	2017-09-14	100,000	$1.70	160,000	No	4	M	Direct
Common Stock	Disposition	2017-09-14	100,000	$27.08	60,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option (right to buy)	Disposition	2017-09-12	100,000	$0.00	100,000	$1.70
Common Stock	Option (right to buy)	Disposition	2017-09-13	100,000	$0.00	100,000	$1.70
Common Stock	Option (right to buy)	Disposition	2017-09-14	100,000	$0.00	100,000	$1.70

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,004,551	2015-07-20	2021-09-18	No	4	M	Direct
904,551	2015-07-20	2021-09-18	No	4	M	Direct
804,551	2015-07-20	2021-09-18	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	172,698	Indirect	By Trust
Common Stock	17,020	Indirect	By 401(k)

Footnotes

Includes 60,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $26.44 to $26.70. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4
Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $26.90 to $27.35. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4
Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $26.97 to $27.20. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4
Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended.
Represents 17,020 shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of September 12, 2017.
The option, representing the right to purchase a total of 1,125,000 shares of Exelixis, Inc. common stock, became exercisable as to fifty percent (50%) of the shares subject to the option on July 20, 2015, as to twenty-five (25%) of the shares subject to the option on March 7, 2016 and as to the remaining twenty-five (25%) of the shares subject to the option on April 28, 2016.